TABLE 5.
Top 10 drug-disease association prediction for dexamethasone and doxorubicin.
| Drug Name | No. | MESH ID | Disease Name | Evidence |
|---|---|---|---|---|
| Dexamethasone MeSH ID: D003907 | 1 | D004342 | Drug Hypersensitivity | ClinicalTrials/CTD/PMID: 28704328 |
| 2 | D000743 | Anemia, Hemolytic | CTD/PMID: 21848879 | |
| 3 | D004417 | Dyspnea | ClinicalTrials/PMID: 27330023 | |
| 4 | D029424 | Chronic Obstructive Pulmonary | Clinical indications | |
| 5 | D008581 | Meningitis | NA | |
| 6 | D002637 | Chest Pain | ClinicalTrials/CTD/PMID: 21799397 | |
| 7 | D010190 | Pancreatic Neoplasms | ClinicalTrials/CTD/PMID: 32619553 | |
| 8 | D002318 | Cardiovascular Diseases | NA | |
| 9 | D009205 | Myocarditis | NA | |
| 10 | D012141 | Respiratory Tract Infections | ClinicalTrials | |
| Doxorubicin MeSH ID:D004317 | 1 | D002289 | Carcinoma, Non-Small-Cell Lung | ClinicalTrials/CTD/PMID: 33075540 |
| 2 | D014652 | Vascular Diseases | ClinicalTrials/Clinical indications | |
| 3 | D009190 | Myelodysplastic Syndromes | ClinicalTrials/CTD/PMID: 27299619 | |
| 4 | D006463 | Hemolytic-Uremic Syndrome | NA | |
| 5 | D002543 | Cerebral Hemorrhage | NA | |
| 6 | D015473 | Leukemia | ClinicalTrials/CTD/PMID: 32949646/Clinical indications | |
| 7 | D017202 | Myocardial Ischemia | NA | |
| 8 | D011658 | Pulmonary Fibrosis | ClinicalTrials/CTD/PMID: 22607134 | |
| 9 | D050197 | Atherosclerosis | NA | |
| 10 | D005910 | Glioma | ClinicalTrials/CTD/PMID: 33475372 |